niacinamide has been researched along with Injuries, Radiation in 18 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sorafenib, an oral inhibitor of multiple tyrosine kinase receptors, has been widely used as a standard medical treatment for advanced hepatocellular carcinoma (HCC)." | 7.81 | Radiation-induced hemorrhagic duodenitis associated with sorafenib treatment. ( Azuma, K; Esaki, M; Kitazono, T; Matsumoto, T; Nakamura, S; Ooho, A; Yanai, S, 2015) |
| " In experimental models carbogen breathing and nicotinamide have been shown to act against hypoxia by different mechanisms and both modalities were tested in 16 patients with supratentorial malignant gliomas in combination with a conventional radiotherapy scheme (50 Gy in 25 daily fractions)." | 5.29 | Conventional radiotherapy combined with carbogen breathing and nicotinamide for malignant gliomas. ( de Koster, A; Grotenhuis, JA; Kaanders, JH; Keyser, A; Prick, MJ; Thijssen, HO; van der Kogel, AJ; van der Maazen, RW; Wesseling, P, 1995) |
| ""ARCON" combines accelerated radiotherapy to counteract tumor repopulation with carbogen breathing and nicotinamide to reduce chronic and acute hypoxia." | 5.10 | ARCON: experience in 215 patients with advanced head-and-neck cancer. ( Bruaset, I; Kaanders, JH; Marres, HA; Merkx, MA; Pop, LA; van den Hoogen, FJ; van der Kogel, AJ, 2002) |
| "Sorafenib, an oral inhibitor of multiple tyrosine kinase receptors, has been widely used as a standard medical treatment for advanced hepatocellular carcinoma (HCC)." | 3.81 | Radiation-induced hemorrhagic duodenitis associated with sorafenib treatment. ( Azuma, K; Esaki, M; Kitazono, T; Matsumoto, T; Nakamura, S; Ooho, A; Yanai, S, 2015) |
| "Sorafenib-treated rats had significantly less fluorescence leakage as compared with vehicle-treated rats (P < 0." | 1.36 | Effect of sorafenib on experimental choroidal neovascularization in the rat. ( Lee, YC; Park, YH; Roh, SY, 2010) |
| " In experimental models carbogen breathing and nicotinamide have been shown to act against hypoxia by different mechanisms and both modalities were tested in 16 patients with supratentorial malignant gliomas in combination with a conventional radiotherapy scheme (50 Gy in 25 daily fractions)." | 1.29 | Conventional radiotherapy combined with carbogen breathing and nicotinamide for malignant gliomas. ( de Koster, A; Grotenhuis, JA; Kaanders, JH; Keyser, A; Prick, MJ; Thijssen, HO; van der Kogel, AJ; van der Maazen, RW; Wesseling, P, 1995) |
| " It is our conclusion that radiotherapy combined with carbogen and nicotinamide is a safe treatment with manageable side effects." | 1.29 | Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicity. ( Kaanders, JH; Marres, HA; Pop, LA; van Daal, WA; van der Kogel, AJ; van der Maazen, RW, 1995) |
| "As the conservative management of breast cancer is now widely adopted, oncologists and physicians should be aware of such rare side effects due to radiation therapy." | 1.29 | Bullous pemphigoid induced by radiation therapy. ( Amanti, C; Di Paola, M; Folliero, G; Tombolini, V; Zurlo, A, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (22.22) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 5 (27.78) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, XY | 1 |
| Liu, KJ | 1 |
| Zhang, FY | 1 |
| Xiang, B | 1 |
| Abdelghany, L | 1 |
| Xu, Y | 1 |
| Sekiya, R | 1 |
| Yan, C | 1 |
| Jingu, K | 1 |
| Li, TS | 3 |
| Kawakatsu, M | 1 |
| Urata, Y | 2 |
| Imai, R | 1 |
| Goto, S | 2 |
| Ono, Y | 2 |
| Nishida, N | 1 |
| Masri, SC | 1 |
| Misselt, AJ | 1 |
| Dudek, A | 1 |
| Konety, SH | 1 |
| Ali, H | 1 |
| Galal, O | 1 |
| Guo, CY | 1 |
| Luo, L | 1 |
| Abdelrahim, E | 1 |
| Mostafa, E | 1 |
| Yanai, S | 1 |
| Nakamura, S | 2 |
| Ooho, A | 1 |
| Esaki, M | 1 |
| Azuma, K | 1 |
| Kitazono, T | 1 |
| Matsumoto, T | 1 |
| Park, YH | 1 |
| Roh, SY | 1 |
| Lee, YC | 1 |
| SEIFULLIN, FKh | 1 |
| YOSHII, G | 1 |
| MIYACHI, M | 1 |
| DETRICK, LE | 1 |
| UPHAM, HC | 1 |
| SPRINGSTEEN, RW | 1 |
| HALEY, TJ | 1 |
| WHITFIELD, JF | 1 |
| BROHEE, H | 1 |
| YOUDALE, T | 1 |
| Zhang, Y | 1 |
| Zheng, X | 1 |
| Li, T | 1 |
| Guo, Y | 1 |
| Hang, R | 1 |
| Lin, J | 1 |
| Gu, W | 1 |
| Peters, NA | 1 |
| Richel, DJ | 1 |
| Verhoeff, JJ | 1 |
| Stalpers, LJ | 1 |
| van der Maazen, RW | 2 |
| Thijssen, HO | 1 |
| Kaanders, JH | 3 |
| de Koster, A | 1 |
| Keyser, A | 1 |
| Prick, MJ | 1 |
| Grotenhuis, JA | 1 |
| Wesseling, P | 1 |
| van der Kogel, AJ | 3 |
| Pop, LA | 2 |
| Marres, HA | 2 |
| van Daal, WA | 1 |
| Folliero, G | 1 |
| Zurlo, A | 1 |
| Amanti, C | 1 |
| Tombolini, V | 1 |
| Di Paola, M | 1 |
| Bruaset, I | 1 |
| van den Hoogen, FJ | 1 |
| Merkx, MA | 1 |
| Horsman, MR | 1 |
1 review available for niacinamide and Injuries, Radiation
| Article | Year |
|---|---|
Nicotinamide and the hypoxia problem.
Topics: Humans; Hypoxia; Neoplasms; Niacinamide; Radiation Injuries; Radiation Tolerance | 1991 |
1 trial available for niacinamide and Injuries, Radiation
| Article | Year |
|---|---|
ARCON: experience in 215 patients with advanced head-and-neck cancer.
Topics: Adult; Aged; Aged, 80 and over; Carbon Dioxide; Dose Fractionation, Radiation; Feasibility Studies; | 2002 |
16 other studies available for niacinamide and Injuries, Radiation
| Article | Year |
|---|---|
Nicotinamide mitigates radiation injury in submandibular gland by protecting mitochondrial structure and functions.
Topics: Adenosine Triphosphate; Animals; DNA Nucleotidylexotransferase; Humans; Mitochondria; NAD; Niacinami | 2022 |
Nicaraven Exerts a Limited Effect on Radiation-Induced Inhibition of Tumor Growth in a Subcutaneous Murine Tumor Model.
Topics: Animals; Antioxidants; Mice; Neoplasms; Niacinamide; Radiation Injuries | 2023 |
Nicaraven attenuates radiation-induced injury in hematopoietic stem/progenitor cells in mice.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Deoxyguanosine; Gamma Rays; Hematopoietic Stem Cells; Interleu | 2013 |
Radiation recall reaction causing cardiotoxicity.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Chemoradiotherapy; Coronary Angiograp | 2014 |
The potential benefits of nicaraven to protect against radiation-induced injury in hematopoietic stem/progenitor cells with relative low dose exposures.
Topics: Animals; Antioxidants; Biomarkers; Gamma Rays; Gene Expression Profiling; Gene Expression Regulation | 2014 |
Radiation-induced hemorrhagic duodenitis associated with sorafenib treatment.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Duodenitis; Gastrointestinal Hemorrhage; Humans; L | 2015 |
Effect of sorafenib on experimental choroidal neovascularization in the rat.
Topics: Animals; Benzenesulfonates; Choroidal Neovascularization; Computer Systems; Disease Progression; Dos | 2010 |
[Effect of coamide on the healing of closed fractures in irradiated animals].
Topics: Animals; Cobalt; Fractures, Bone; Fractures, Closed; Niacin; Niacinamide; Organometallic Compounds; | 1962 |
RADIATION INJURY TO MEMBRANE PERMEABILITY OF ELECTROLYTES.
Topics: Adenosine Triphosphate; Cell Membrane Permeability; Cesium Isotopes; Electrolytes; Erythrocytes; Glu | 1963 |
INCREASED INTESTINAL ELIMINATION OF N'-METHYLNICOTINAMIDE IN IRRADIATED RATS.
Topics: Intestinal Elimination; Intestine, Small; Intestines; Metabolism; Niacin; Niacinamide; Radiation Inj | 1963 |
PREVENTION OF NUCLEAR CHANGES IN IRRADIATED RAT THYMOCYTES BY NICOTINAMIDE.
Topics: Cell Nucleus; Niacinamide; Pharmacology; Radiation Injuries; Radiation Injuries, Experimental; Radia | 1964 |
Radiotoxicity on bone marrow after 89Sr therapy radiosensitized by nicotinamide and carbogen in mice.
Topics: Administration, Inhalation; Animals; Bone Marrow; Carbon Dioxide; Chromosomes; Female; Injections, I | 2004 |
Bowel perforation after radiotherapy in a patient receiving sorafenib.
Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Combined Modality Therapy; Female; | 2008 |
Conventional radiotherapy combined with carbogen breathing and nicotinamide for malignant gliomas.
Topics: Administration, Inhalation; Aged; Brain Neoplasms; Carbon Dioxide; Combined Modality Therapy; Female | 1995 |
Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicity.
Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Aged, 80 and over; Carbon Dioxide; Ca | 1995 |
Bullous pemphigoid induced by radiation therapy.
Topics: Anti-Bacterial Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Dermatologic Agents; Female; Hum | 1995 |